Saturday 20 December 2014

Resistance to Anti-Viral Medication may be More Likely in Cystic Fibrosis Patients

A drug called ganciclovir is given to lung transplant patients to protect against a life-threatening virus that is common after transplantation. Ganciclovir reduces mortality due to the virus from 34 percent to between 3 and 6 percent. But between 5 percent and 10 percent of patients infected with the virus have strains that are resistant to the drug. A Loyola University Medical Center study found that such resistance may occur more frequently in cystic ...

via Medindia Health News More READ

No comments:

Post a Comment